retatrutide type 2 diabetes phase 2 trial results π¨ Today, retatrutide, the GIP/GLP-1/glucagon triple agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent obesity and diabetes. π Mean body weight change at 80 weeks: β¬οΈ retatrutide type 2 diabetes phase
Pay in 4 interest-free payments of $7.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 22 - Aug 27
























/sc-assets/prd/practices/cdcd65da-a892-465a-aa2c-48d5c1f8134f/Semaglutide%20vial.png)





